Syringe with a Pill.
i2o Therapeutics has developed a disruptive ionic liquid technology, enabling the oral delivery of peptides, proteins, and other injection-based drugs.
Using an innovative ionic liquid technology, this platform leverages the benefits of protecting the drug cargo while also transiently enhancing permeation across the epithelial lining when administered orally.
i2o is focused on creating the next generation of oral peptide and protein-based therapies.
Revolutionary Oral Delivery Platform
Low Cost of Goods
Superior Drug Loading
Compatible with Diverse Drug Types